We have proposed our original guidelines for management of patients receiving bisphosphonates (BPs) in 2008, and have managed 666 patients according to our guidelines till February 2013. Patients were classified…
Background and objectives : Since the first description of bisphosphonates related osteonecrosis of the jaw (BRONJ) made in 2003 there has been an increased number of cases described in the…
Background and objectives : Treatment of bisphosphonate (BP)-induced osteonecrosis of the jaws (ONJ) varies from conservative to surgical and there exist no global consensus. Since 2010 we have used a…
Background : Bisphosphonate-related osteonecrosis of the jaw has become a well known problem of rising clinical importance. The treatment is exceptionally hard. Fluorescence guided bone resection is a promising technique…
Background and objetives : Bisphosphonates are antiresorptive drug fully accepted for the treatment of metastatic bone disease, osteoporosis and other bone diseases. In 2003, Marx published 36 patients with exposed…
Background : Osteonecrosis of the jaw occurs in patients receiving high doses of intravenous nitrogen-containing bisphosphonates in the course of their supportive cancer therapy. The exact pathomechanisms are elusive and…
Treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) remains an intractable problem in many cases. Recent literatures have shown that the new treatment modality using teriparatide may be beneficial to…
Background and objects : The radiographic criteria of bisphosphonate-related osteonecrosis of the jaws (BRONJ) have only been investigated in few studies yet. All of them comprised just limited cohorts. It…
Objectives : To evaluate functional condition of the inferior alveolar nerve in acute odontogenic inflammatory processes of mandible by means of the stimulative electroneuromyography. Methods : Sixty patients with acute…
Background : Bone biomarkers have been suggested for the risk assessment for osteonecrosis of the jaw, a serious complication associated with bisphosphonate (BP) use; however, no consensus has been reached….
